PWM
TRAW icon

Palumbo Wealth Management’s Traws Pharma TRAW Stock Holding History

Palumbo Wealth Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-61,175
Closed -$112K – 249
2026
Q1 		$112K Buy
+61,175
New +$115K 0.03% 217

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Palumbo Wealth Management's TRAW Position: Q2 2026 in Review

Palumbo Wealth Management sold out of Traws Pharma (TRAW) in Q2 2026, closing a stake of 61,175 shares — an estimated $112K sold.

Palumbo Wealth Management first reported a position in TRAW in Q1 2026 and held it in 1 quarter. The position peaked at $112K in Q1 2026. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Palumbo Wealth Management reported no remaining Traws Pharma position as of Q2 2026 after selling out during the quarter.
  • Palumbo Wealth Management sold 61,175 Traws Pharma shares in Q2 2026, an estimated $112K.
  • Palumbo Wealth Management first reported a position in Traws Pharma in Q1 2026 and held it in 1 quarter.
  • Palumbo Wealth Management's Traws Pharma position peaked at $112K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.